文献速递浆细胞疾病

补肾活血通络方代谢产物对多发性骨髓瘤KM3细胞增殖的影响及机制

[Effects and mechanisms of the kidney-reinforcing and blood circulation-activating and collateral dredging decoction metabolites on the proliferation of multiple myeloma KM3 cells].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2025-01-01

该研究用3%、6%、9%、12%的补肾活血通络方代谢产物处理多发性骨髓瘤KM3细胞,发现其以剂量依赖性方式抑制细胞增殖并诱导凋亡,上调Drp1、Fis1、MFF、Pink1、Parkin表达,12%组差异最显著(P<0.01),并鉴定出121个活性成分与474个交集靶点。

要点

  • 补肾活血通络方代谢产物抑制KM3细胞增殖并诱导凋亡,呈剂量依赖性。
  • 3%–12%代谢产物组Drp1、Fis1、MFF、Pink1、Parkin的mRNA和蛋白表达较对照组均升高(P<0.05)。
  • 12%代谢产物组与对照组差异最显著(P<0.01),电镜下线粒体分裂和自噬结构随浓度升高而增多。

核心结论

  • 补肾活血通络方可抑制MM KM3细胞增殖,其机制可能与调控线粒体分裂、诱导细胞自噬相关。

研究设计与样本

  • 体外研究:用含3%、6%、9%、12%补肾活血通络方代谢产物处理对数生长期MM KM3细胞株。
  • 采用CCK-8法检测细胞活力,流式细胞术和TUNEL染色检测凋亡和坏死。
  • 透射电子显微镜观察细胞结构,荧光定量PCR和Western blot检测Drp1、Fis1、MFF、Pink1、Parkin的mRNA和蛋白表达。
  • HPLC-MS/MS结合网络药理学对药效基础与作用靶点进行反向验证。

主要发现

  • 补肾活血通络方代谢产物抑制KM3细胞增殖并诱导凋亡,呈剂量依赖性。
  • 透射电镜显示3%、6%、9%、12%代谢产物组细胞内线粒体分裂和细胞自噬数量较对照组增多,并随代谢产物浓度升高而递增。
  • Drp1、Fis1、MFF、Pink1、Parkin的mRNA和蛋白表达水平较对照组均升高(P值均<0.05),其中12%代谢产物组与对照组差异最显著(P<0.01)。
  • HPLC-MS/MS从补肾活血通络方中鉴别筛选出121个活性成分,与MM有474个交集靶点。
  • 富集分析提示补肾活血通络方可能通过芹菜素、黄藤素等主要活性成分调控肿瘤坏死因子、核因子κB、线粒体自噬等通路发挥抗肿瘤作用。

关键数值与推荐

  • 3%、6%、9%、12%代谢产物组Drp1、Fis1、MFF、Pink1、Parkin的mRNA和蛋白表达较对照组均升高(P<0.05)。
  • 12%代谢产物组与对照组差异最显著(P<0.01)。
  • HPLC-MS/MS鉴别出121个活性成分,与MM有474个交集靶点。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the effects and underlying mechanisms of metabolites derived from the kidney-reinforcing, blood circulation-activating, and collateral dredging decoction on the proliferation of multiple myeloma (MM) KM3 cells. Methods: MM KM3 cells in the logarithmic growth phase were treated with 3%, 6%, 9%, or 12% metabolites of kidney-reinforcing, blood circulation-activating, and collateral dredging decoction. Cell viability was assessed using the CCK-8 assay. Apoptosis and necrosis were evaluated using flow cytometry and TUNEL staining. Mitochondrial and cellular ultrastructural changes were examined using transmission electron microscopy. mRNA and protein expression levels of dynamin-related protein 1 (Drp1), mitochondrial fission protein 1 (Fis1), mitochondrial fission factor (MFF), PTEN-induced kinase 1 (Pink1), and E3 ubiquitin ligase (Parkin) were determined through quantitative real-time PCR and western blotting. High-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) combined with network pharmacology, was utilized for reverse verification of the pharmacodynamic mechanisms and therapeutic targets underlying the anti-MM activity of this decoction. Results: The metabolites of the kidney-reinforcing, blood circulation-activating, and collateral dredging decoction inhibited KM3 cell proliferation and induced apoptosis in a dose-dependent manner. Transmission electron microscopy revealed increased mitochondrial fission and autophagic structures, with effects intensifying at higher metabolite concentrations. mRNA and protein expression of Drp1, Fis1, MFF, Pink1, and Parkin were significantly upregulated in treatment groups compared to controls (P<0.05), with the most pronounced effects observed in the 12% metabolite group (P<0.01). HPLC-MS/MS identified 121 bioactive compounds in BHTF, which shared 474 overlapping targets with MM. Enrichment analysis suggested that BHTF exerts antitumor effects primarily through apigenin, palmatine, and other key components by modulating TNF, NF-κB, and mitophagy pathways. Conclusion: The kidney-reinforcing and blood circulation-activating and collateral dredging decoction suppresses the proliferation of MM KM3 cells, potentially through mechanisms involving the regulation of mitochondrial dynamics and induction of autophagy. 目的: 探索补肾活血通络方代谢产物对多发性骨髓瘤(MM)KM3细胞增殖的影响及其作用机制。 方法: 分别用含3%、6%、9%、12%的补肾活血通络方代谢产物处理对数生长期的MM KM3细胞株,CCK-8法检测KM3细胞活力,采用流式细胞术和TUNEL染色法检测细胞凋亡和坏死情况。通过透射电子显微镜观察细胞结构,荧光定量PCR和Western blot检测动力相关蛋白1(Drp1)、线粒体裂变蛋白1(Fis1)、线粒体分裂因子(MFF)、PTEN诱导激酶1(Pink1)和E3泛素连接酶(Parkin)的mRNA和蛋白表达水平。通过高效液相色谱-串联质谱(HPLC-MS/MS)技术结合网络药理学对补肾活血通络方治疗MM的药效基础与作用靶点进行反向验证。 结果: 补肾活血通络方代谢产物抑制KM3细胞增殖,诱导细胞凋亡,并呈剂量依赖性。透射电镜观察细胞结构显示,与对照组相比,3%、6%、9%、12%代谢产物组细胞内线粒体分裂和细胞自噬数量增多,并随代谢产物浓度的升高而递增。Drp1、Fis1、MFF、Pink1、Parkin的mRNA和蛋白的表达水平较对照组均升高(P值均<0.05),其中12%代谢产物组与对照组的差异最为显著(P<0.01)。通过HPLC-MS/MS技术从补肾活血通络方中鉴别筛选出121个活性成分,与MM有474个交集靶点,富集分析结果表明,补肾活血通络方可能通过芹菜素、黄藤素等主要活性成分调控肿瘤坏死因子、核因子κB、线粒体自噬等通路发挥抗肿瘤作用。 结论: 补肾活血通络方可抑制MM KM3细胞增殖,其机制可能与调控线粒体分裂、诱导细胞自噬相关。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Shi JB, Li CN, Wei WJ, et al. [Effects and mechanisms of the kidney-reinforcing and blood circulation-activating and collateral dredging decoction metabolites on the proliferation of multiple myeloma KM3 cells]. Zhonghua Xue Ye Xue Za Zhi. 2025. PMID: 40887422. doi:10.3760/cma.j.cn121090-20241209-00547

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。